Liver endothelial cells, endothelial cell media, kupffer cells, hepatic stellate cells
Ended Awarded Last action
- Contract number
- 75N95024F00001
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $23,379
Award facts
- Opportunity
-
- 75N95024Q00490 Solicitation number
- Contract value 100% obligated
- $23,379.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award to Lonza Walkersville, Inc. is for the delivery of specialized biological materials including liver endothelial cells, endothelial cell media, Kupffer cells, and hepatic stellate cells. The $23,379.04 firm-fixed-price contract was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. This award is likely to support NCATS' mission of accelerating the development and delivery of new treatments and diagnostics. As a leading supplier of cell culture products and laboratory equipment, Lonza Walkersville has a long history of supporting biomedical research across multiple government agencies. The contract is not designated as a set-aside and is a call against an existing Blanket Purchase Agreement the company holds with NCATS, enabling efficient ordering of a wide range of critical research materials and instrumentation.
Quick answers
Who was awarded contract 75N95024F00001?
75N95024F00001 was awarded to Lonza Walkersville, Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 18, 2024.
How much is contract 75N95024F00001 worth?
The government has obligated $23,379 on 75N95024F00001.
Which agency awarded contract 75N95024F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95024F00001 an order under another contract?
Yes. 75N95024F00001 is a BPA call under 75N98024A00050, a blanket purchase agreement.
Was contract 75N95024F00001 competed?
The extent of competition for 75N95024F00001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award